CYX.F - Cardlytics, Inc.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
298,542
298,542
267,116
186,892
210,430
Cost of revenue
185,910
185,910
163,776
123,618
130,973
Gross profit
112,632
112,632
103,340
63,274
79,457
Operating expenses
Research development
54,435
54,435
38,104
17,532
11,699
Selling general and administrative
156,191
156,191
132,218
91,839
80,548
Total operating expenses
248,170
248,170
200,193
117,197
96,782
Operating income or loss
-135,538
-135,538
-96,853
-53,923
-17,325
Interest expense
3,994
2,556
12,563
3,048
1,377
Total other income/expenses net
-328,616
-328,616
-27,013
1,549
729
Income before tax
-466,710
-466,710
-136,429
-55,422
-17,144
Income tax expense
-1,446
-1,446
-7,864
0
0
Income from continuing operations
-465,264
-465,264
-128,565
-55,422
-17,144
Net income
-465,264
-465,264
-128,565
-55,422
-17,144
Net income available to common shareholders
-465,264
-465,264
-128,565
-55,422
-17,144
Basic EPS
-
-13.92
-3.99
-2.04
-0.72
Diluted EPS
-
-13.92
-3.99
-2.04
-0.72
Basic average shares
-
33,419
32,202
27,213
23,746
Diluted average shares
-
33,419
32,202
27,213
23,746
EBITDA
-
-420,414
-88,212
-42,331
-12,790